These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18350678)

  • 21. Strategies to reduce oxidative stress in cardiovascular disease.
    Hamilton CA; Miller WH; Al-Benna S; Brosnan MJ; Drummond RD; McBride MW; Dominiczak AF
    Clin Sci (Lond); 2004 Mar; 106(3):219-34. PubMed ID: 14733610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of non-ACE-dependent angiotensin II-forming system].
    Urata H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():27-33. PubMed ID: 16897850
    [No Abstract]   [Full Text] [Related]  

  • 23. [Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Okigaki M; Iwasaka T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():139-43. PubMed ID: 15171357
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endothelial protection by angiotensin II type-1 receptor blockade].
    Yamada H; Matsui A; Tsubakimoto Y; Yokoi H; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():482-6. PubMed ID: 16897883
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin receptor blockers: current status and future prospects.
    Kumar S; Ram CV
    Indian Heart J; 2007; 59(6):443-53. PubMed ID: 19151457
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiinflammatory action of angiotensin receptor blocker].
    Katagiri T; Takei M; Sakurai M; Matsuyama T; Sakai T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():506-11. PubMed ID: 16895219
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin resistance and vascular function].
    Naruse M; Tanabe A; Takagi S; Tago K; Takano K
    Nihon Rinsho; 2000 Feb; 58(2):344-7. PubMed ID: 10707556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
    Egido J; Ruiz-Ortega M; Muñoz-García B; Martín-Ventura JL; Blanco-Colio LM
    Nefrologia; 2005; 25 Suppl 2():117-28. PubMed ID: 16050414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiological significance of RAS in formation of arteriosclerosis].
    Matsubara H; Yamada H; Tsubakimoto Y; Yokoi H
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1762-8. PubMed ID: 17037312
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of heterologous receptor desensitization induced by angiotensin II type 1 receptor activation in isolated normal rat thoracic aorta.
    Pérez T; López RM; López P; Castillo C; Castillo EF
    Vascul Pharmacol; 2011; 54(1-2):29-35. PubMed ID: 21122823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of the metabolic syndrome.
    Grant RW; Meigs JB
    Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acceleration of cellular senescence].
    Imanishi T; Akasaka T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():70-4. PubMed ID: 16897855
    [No Abstract]   [Full Text] [Related]  

  • 35. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
    Jacoby DS; Rader DJ
    Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II antagonists--therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy.
    Ribeiro AB
    Curr Med Res Opin; 2006 Jan; 22(1):1-16. PubMed ID: 16393425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress and cardiovascular injury: Part II: animal and human studies.
    Griendling KK; FitzGerald GA
    Circulation; 2003 Oct; 108(17):2034-40. PubMed ID: 14581381
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathogenesis and etiology of cardiovascular disease: role of insulin resistance].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():163-8. PubMed ID: 17458212
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II receptor blockers and insulin resistance.
    Ciccarelli L
    Hypertens Res; 2010 Aug; 33(8):779. PubMed ID: 20535122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanical stress in cardiovascular remodeling].
    Yasuda N; Akazawa H; Komuro I
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():229-33. PubMed ID: 16897864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.